Tessellate BIO is a preclinical biotechnology company specializing in advanced Synthetic Lethality techniques. It develops precision oncology solutions aimed at treating tumors with significant unmet medical needs, offering innovative approaches to cancer treatment that promise to enhance patient outcomes and address critical challenges in oncology.